March 22, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis
📊 The performance of key healthcare stocks has been a mixed bag across different timeframes. Short-term rallies and declines are evident, particularly for Eli Lilly and Thermo Fisher Scientific. Over three months, Johnson & Johnson emerged as a strong performer, emphasizing its resilience amidst sector volatility.
Healthcare Stocks Performance One Week
🔍 Over the past week, Thermo Fisher Scientific (TMO) outperformed its peers with a significant gain, indicating a short-term positive sentiment in the market. Eli Lilly (LLY) saw the largest decline, suggesting some investor caution.
| Stock | Performance (%) | Performance |
|---|---|---|
| TMO | 2.17 | |
| ISRG | 1.26 | |
| MRK | -1.24 | |
| UNH | -2.29 | |
| ABT | -2.35 | |
| JNJ | -2.56 | |
| AMGN | -5.11 | |
| ABBV | -6.72 | |
| LLY | -8.09 |
Healthcare Stocks Performance One Month
🔍 The monthly performance reflects broader market challenges, with Eli Lilly again experiencing the greatest decline. UnitedHealth Group (UNH) and Abbott Laboratories (ABT) underscoring sector-wide pressures.
| Stock | Performance (%) | Performance |
|---|---|---|
| JNJ | -2.89 | |
| UNH | -4.76 | |
| ABT | -5.97 | |
| ISRG | -5.10 | |
| MRK | -6.61 | |
| ABBV | -8.85 | |
| TMO | -7.12 | |
| AMGN | -7.23 | |
| LLY | -10.23 |
Healthcare Stocks Performance Three Months
🔍 Over three months, Johnson & Johnson (JNJ) shows a reverse trend with substantial gains, while the majority of other healthcare stocks, notably Intuitive Surgical (ISRG) and Thermo Fisher Scientific (TMO), displayed significant declines.
| Stock | Performance (%) | Performance |
|---|---|---|
| JNJ | 12.99 | |
| MRK | 9.25 | |
| AMGN | 5.97 | |
| ABBV | -9.62 | |
| LLY | -15.16 | |
| UNH | -13.41 | |
| TMO | -18.48 | |
| ABT | -16.19 | |
| ISRG | -18.61 |
Summary
💡 Overall, Johnson & Johnson's robust three-month performance stands out amidst sector challenges. The healthcare sector, as evidenced by companies like Eli Lilly and Thermo Fisher Scientific, has faced notable headwinds. Going forward, investors may find value in selectively identifying resilient stocks and considering broader market conditions before making investment decisions.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years